Advanced search
1 file | 1.63 MB

Hepatitis B core-based virus-like particles to present heterologous epitopes

Kenny Roose (UGent) , Sarah De Baets (UGent) , Bert Schepens (UGent) and Xavier Saelens (UGent)
(2013) EXPERT REVIEW OF VACCINES. 12(2). p.183-198
Author
Organization
Abstract
Since the first effort to recombinantly express the hepatitis B core protein (HBc) in bacteria, the remarkable virion-like structure has fuelled interest in unraveling the structural and antigenic properties of this protein. Initial studies proved HBc virus-like particles to possess strong immunogenic properties, which can be conveyed to linked antigens. More than 35 years later, numerous studies have been performed using HBc as a carrier protein for antigens derived from over a dozen different pathogens and diseases. In this review, the authors highlight the intriguing features of HBc as carrier and antigen, illustrated by some examples and experimental results that underscore the value of HBc as an antigen-presenting platform. Two of these HBc fusions, targeting influenza A and malaria, have even progressed into clinical testing. In the future, the HBc-based virus-like particles platform will probably continue to be used for the display of poorly immunogenic antigens, mainly because virus-like particle formation by HBc capsomers is compatible with nearly any available recombinant gene expression system.
Keywords
arrayed epitope display, B-cell immunity, hepatitis B virus, influenza, malaria, T-cell immunity, virus-like particles, INFLUENZA-A VACCINE, MOUTH-DISEASE VIRUS, FALCIPARUM CIRCUMSPOROZOITE-PROTEIN, RECEPTOR-BINDING SITE, LARGE SURFACE PROTEIN, ION-CHANNEL ACTIVITY, T-CELL RECOGNITION, PHASE-I TRIAL, PLASMODIUM-FALCIPARUM, MALARIA VACCINE

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.63 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Roose, Kenny, Sarah De Baets, Bert Schepens, and Xavier Saelens. 2013. “Hepatitis B Core-based Virus-like Particles to Present Heterologous Epitopes.” Expert Review of Vaccines 12 (2): 183–198.
APA
Roose, K., De Baets, S., Schepens, B., & Saelens, X. (2013). Hepatitis B core-based virus-like particles to present heterologous epitopes. EXPERT REVIEW OF VACCINES, 12(2), 183–198.
Vancouver
1.
Roose K, De Baets S, Schepens B, Saelens X. Hepatitis B core-based virus-like particles to present heterologous epitopes. EXPERT REVIEW OF VACCINES. 2013;12(2):183–98.
MLA
Roose, Kenny, Sarah De Baets, Bert Schepens, et al. “Hepatitis B Core-based Virus-like Particles to Present Heterologous Epitopes.” EXPERT REVIEW OF VACCINES 12.2 (2013): 183–198. Print.
@article{3170366,
  abstract     = {Since the first effort to recombinantly express the hepatitis B core protein (HBc) in bacteria, the remarkable virion-like structure has fuelled interest in unraveling the structural and antigenic properties of this protein. Initial studies proved HBc virus-like particles to possess strong immunogenic properties, which can be conveyed to linked antigens. More than 35 years later, numerous studies have been performed using HBc as a carrier protein for antigens derived from over a dozen different pathogens and diseases. In this review, the authors highlight the intriguing features of HBc as carrier and antigen, illustrated by some examples and experimental results that underscore the value of HBc as an antigen-presenting platform. Two of these HBc fusions, targeting influenza A and malaria, have even progressed into clinical testing. In the future, the HBc-based virus-like particles platform will probably continue to be used for the display of poorly immunogenic antigens, mainly because virus-like particle formation by HBc capsomers is compatible with nearly any available recombinant gene expression system.},
  author       = {Roose, Kenny and De Baets, Sarah and Schepens, Bert and Saelens, Xavier},
  issn         = {1476-0584},
  journal      = {EXPERT REVIEW OF VACCINES},
  keywords     = {arrayed epitope display,B-cell immunity,hepatitis B virus,influenza,malaria,T-cell immunity,virus-like particles,INFLUENZA-A VACCINE,MOUTH-DISEASE VIRUS,FALCIPARUM CIRCUMSPOROZOITE-PROTEIN,RECEPTOR-BINDING SITE,LARGE SURFACE PROTEIN,ION-CHANNEL ACTIVITY,T-CELL RECOGNITION,PHASE-I TRIAL,PLASMODIUM-FALCIPARUM,MALARIA VACCINE},
  language     = {eng},
  number       = {2},
  pages        = {183--198},
  title        = {Hepatitis B core-based virus-like particles to present heterologous epitopes},
  url          = {http://dx.doi.org/10.1586/ERV.12.150},
  volume       = {12},
  year         = {2013},
}

Altmetric
View in Altmetric
Web of Science
Times cited: